Inventor
KOLENG JOHN J
US24 patents
⚠️ This page may combine multiple inventors who share the name “KOLENG JOHN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BODOR LABORATORIES INC
12 patentsUS10961191B2Mar 30, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC9 citations85
US11123325B2Sep 21, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC4 citations84
US11084788B2Aug 10, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC8 citations84
US11052067B2Jul 6, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC8 citations84
US11034652B2Jun 15, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC8 citations84
US10959983B2Mar 30, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC8 citations84
US10947192B2Mar 16, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC8 citations84
US11026919B2Jun 8, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC4 citations73
US10952990B2Mar 23, 2021
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC4 citations73
US12398102B2Aug 26, 2025
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC0 citations62
US12357609B2Jul 15, 2025
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC0 citations62
US12156865B2Dec 3, 2024
Formulation for soft anticholinergic analogs
BODOR LABORATORIES INC0 citations62
CROWLEY MICHAEL M
3 patentsUS8173152B2May 8, 2012
Stabilized compositions containing alkaline labile drugs
CROWLEY MICHAEL M17 citations89
US8883187B2Nov 11, 2014
Stabilized compositions containing alkaline labile drugs
CROWLEY MICHAEL M2 citations60
US8465759B2Jun 18, 2013
Process for the preparation of a hot-melt extruded laminate
CROWLEY MICHAEL M3 citations60
LUNG THERAPEUTICS INC
2 patentsUS11905336B2Feb 20, 2024
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
LUNG THERAPEUTICS INC1 citations69
US11787838B2Oct 17, 2023
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis
LUNG THERAPEUTICS INC2 citations69